Literature DB >> 15224872

Tegmen tympani cerebrospinal fluid leak repair.

Ricardo Ferreira Bento1, Francini Grecco de Melo Pádua.   

Abstract

OBJECTIVE: To describe the transmastoid approach for closing cerebrospinal fluid leaks in the tegmen tympani using autologous materials (temporal muscle fascia and abdominal fat) and heterologous materials (bovine collagen), together with its advantages and disadvantages.
MATERIAL AND METHODS: We present the cases of three patients who underwent closure of spontaneous cerebrospinal fluid leaks in the tegmen tympani in which we used the transmastoid approach and autologous and heterologous materials. The three patients underwent canal wall-up mastoidectomy, posterior tympanotomy, removal of the malleus head and incus and, consequently, exposure of the tegmen tympani and the cerebrospinal fluid leak. Closure was performed using temporal muscle fascia, abdominal fat and bovine collagen, fixed in place with fibrin glue. A lumbar shunt was established, as is routine.
RESULTS: The cerebrospinal fluid leak was closed in all patients using the technique described, with a minimum follow-up of 14 months.
CONCLUSION: The technique presented herein is an excellent option in cases of cerebrospinal fluid leakage in the tegmen tympani; it is easy to perform and results in minimal risk to patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15224872     DOI: 10.1080/00016480410016469

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  2 in total

1.  Repair of spontaneous cerebrospinal fluid otorrhea from defect of middle cranial fossa.

Authors:  Sung Hyun Boo; Young Bum Goh; Chi-Sung Han
Journal:  Korean J Audiol       Date:  2013-12-13

2.  Repair of bony lateral skull base defects equal to or larger than 10 mm by extracorporeally sewed unit-sandwich graft.

Authors:  Shabbir Indorewala; Gaurav Nemade; Abuzar Indorewala; Gauri Mahajan
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-23       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.